Filing Details
- Accession Number:
- 0001493152-19-014109
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-09-13 17:20:11
- Reporting Period:
- 2019-09-11
- Accepted Time:
- 2019-09-13 17:20:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1642380 | Oncocyte Corp | OCX | Biological Products, (No Disgnostic Substances) (2836) | CA |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 876343 | Lineage Cell Therapeutics, Inc. | 2173 Salk Avenue, Suite 200 Carlsbad CA 92008 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, No Par Value | Disposition | 2019-09-11 | 4,000,000 | $1.66 | 8,424,244 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Billionaire Hedge Funds
